Distribution of ABCB1 Polymorphisms Among Brazilians: Impact of Population Admixture
Overview
Pharmacology
Authors
Affiliations
Introduction: Interethnic admixture is a source of cryptic population structure that may lead to spurious genotype-phenotype associations in pharmacogenomic studies. We studied the impact of population stratification on the distribution of ABCB1 polymorphisms (1236C>T, 2677G>T/A and 3435C>T) among Brazilians, a highly admixed population with Amerindian, European and African ancestral roots.
Methods: Individual DNA from 320 healthy adults was genotyped with a panel of ancestry informative markers, and the proportions of African component of ancestry (ACA) were estimated. ABCB1 genotypes were determined by the single base extension/termination method. We describe the association between ABCB1 polymorphisms and ACA by fitting a linear proportional odds logistic regression model to the data.
Results: The distribution of the ABCB1 2677G>T/A and 3435C>T, but not the 1236C>T, SNPs displayed a significant trend for decreasing frequency of the T alleles and TT genotypes from White to Intermediate to Black individuals. The same trend was observed in the frequency of the T/nonG/T haplotype at the 1236, 2677 and 3435 loci. When the population sample was proportioned in quartiles, according to the individual ACA estimates, the frequency of the T allele and TT genotype at each locus declined progressively from the lowest (< 0.25 ACA) to the highest (> 0.75 ACA) quartile. Linear proportional odds logistic regression analysis confirmed that the odds of having the T allele at each locus decreases in a continuous manner with the increase of the ACA, throughout the ACA range (0.13-0.94) observed in the overall population sample. A significant association was also detected between the individual ACA estimates and the presence of the T/nonG/T haplotype in the overall population.
Conclusion: Self-identification according to the racial/color categories proposed by the Brazilian Census is insufficient to properly control for population stratification in pharmacogenomic studies of ABCB1.
Pharmacogenetic Testing in Treatment-resistant Panic Disorder: a Preliminary Analysis.
Fidry M, Zugliani M, do Cabo M, Martins R, Gomez M, Faria C Clin Pract Epidemiol Ment Health. 2025; 20():e17450179337258.
PMID: 39839219 PMC: 11748058. DOI: 10.2174/0117450179337258241031035148.
Seligson N, Zhang X, Zemanek M, Johnson J, VanGundy Z, Wang D Front Pharmacol. 2024; 14:1334440.
PMID: 38259277 PMC: 10800424. DOI: 10.3389/fphar.2023.1334440.
Korkor M, El-Desoky T, Mosaad Y, Salah D, Hammad A Ital J Pediatr. 2023; 49(1):57.
PMID: 37198710 PMC: 10193607. DOI: 10.1186/s13052-023-01469-w.
Biswas M Pharmacogenomics. 2021; 22(6):375-381.
PMID: 33759544 PMC: 7989382. DOI: 10.2217/pgs-2020-0096.
Dos Santos I, Genre J, Marques D, da Silva A, Dos Santos J, de Araujo J BMC Med Genet. 2017; 18(1):140.
PMID: 29178884 PMC: 5702224. DOI: 10.1186/s12881-017-0502-8.